Related Experiment Video
Updated: Jun 15, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
BGformer: An improved Informer model to enhance blood glucose prediction
Yuewei Xue1, Shaopeng Guan1, Wanhai Jia1
1School of Information and Electronic Engineering, Shandong Technology and Business University, Yantai, 264003, China.
None:
Accurately predicting blood glucose levels is crucial in diabetes management to mitigate patients' risk of complications. However, blood glucose values exhibit instability, and existing prediction methods often struggle to capture their volatile nature, leading to inaccurate trend forecasts. To address these challenges, we propose a novel blood glucose level prediction model based on the Informer architecture: BGformer. Our model introduces a feature enhancement module and a microscale overlapping concerns mechanism. The feature enhancement module integrates periodic and trend feature extractors, enhancing the model's ability to capture relevant information from the data. By extending the feature extraction capacity of time series data, it provides richer feature representations for analysis. Meanwhile, the microscale overlapping concerns mechanism adopts a window-based strategy, computing attention scores only within specific windows. This approach reduces computational complexity while enhancing the model's capacity to capture local temporal dependencies. Furthermore, we introduce a dual attention enhancement module to augment the model's expressive capability. Through prediction experiments on blood glucose values from sixteen diabetic patients, our model outperformed eight benchmark models in terms of both MAE and RMSE metrics for future 60-minute and 90-minute predictions. Our proposed scheme significantly improves the model's dependency-capturing ability, resulting in more accurate blood glucose level predictions.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Diabetes Mellitus: Type 2 and Gestational
Insulin Secretory Vesicles
Pre-Procedural Guidelines for Assessing Blood Pressure

